Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kalra

Showing results (451-460 of 486) with videos related to

Pageof 49
Sort By:
Kidney International Reports|August 13, 2021
Randomized Trial-PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving HemodialysisSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
Health Technology Assessment (Winchester, England)|June 22, 2021
Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCTSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Kidney International|September 18, 2014
Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosisAndrew F Malone, Paul J Phelan, Gentzon Hall, et al.
Journal of the American College of Cardiology|October 23, 2024
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart FailureJohn G F Cleland, Pierpaolo Pellicori, Fraser J Graham, et al.
Health Technology Assessment (Winchester, England)|July 26, 2024
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C studyEdmund J Lamb, Jonathan Barratt, Elizabeth A Brettell, et al.
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
BMJ (Clinical Research Ed.)|March 19, 2026
Accuracy of glomerular filtration rate estimation based on creatinine and cystatin C for monitoring moderate chronic kidney disease in adults: prospective, longitudinal cohort studyKatie Scandrett, Alice J Sitch, Jonathan Barratt, et al.
Kidney International|April 17, 2018
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across EuropeKatharina Brück, Kitty J Jager, Carmine Zoccali, et al.
Pageof 49

Showing results (451-460 of 486) with videos related to

Sort By:
Pageof 49
Kidney International Reports|August 13, 2021
Randomized Trial-PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving HemodialysisSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
Health Technology Assessment (Winchester, England)|June 22, 2021
Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCTSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Kidney International|September 18, 2014
Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosisAndrew F Malone, Paul J Phelan, Gentzon Hall, et al.
Journal of the American College of Cardiology|October 23, 2024
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart FailureJohn G F Cleland, Pierpaolo Pellicori, Fraser J Graham, et al.
Health Technology Assessment (Winchester, England)|July 26, 2024
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C studyEdmund J Lamb, Jonathan Barratt, Elizabeth A Brettell, et al.
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
BMJ (Clinical Research Ed.)|March 19, 2026
Accuracy of glomerular filtration rate estimation based on creatinine and cystatin C for monitoring moderate chronic kidney disease in adults: prospective, longitudinal cohort studyKatie Scandrett, Alice J Sitch, Jonathan Barratt, et al.
Kidney International|April 17, 2018
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across EuropeKatharina Brück, Kitty J Jager, Carmine Zoccali, et al.
Pageof 49